Usually, in patients with GERD or intermediate and poor metabolizer CYP2C19 genotype, the proportion of time for which the stomach is characterized by pH < 4 decreases to approximately 50 % with PPI [4, 5]. Here, CYP2C19 is linked to gastroesophageal reflux disease.